Ninth Dorsal Osteopathic Visceral Manipulation D9
1 other identifier
interventional
87
0 countries
N/A
Brief Summary
The aims of this study is to verify that the vertebral manipulation of dorsal level D9 influences the pancreas biochemical and endocrinology blood values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 20, 2019
CompletedFirst Posted
Study publicly available on registry
February 25, 2019
CompletedFebruary 25, 2019
February 1, 2019
6 months
February 20, 2019
February 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Basal insulin laboratory value change
The normal values of basal insulin measured with the imunoanalysis method are ˂ at 25.0 mU / l. If these values are exceeded, the effect of the manipulation in the study is verified
10 minutes
Basal glycemia laboratory value change
The normal values of basal glycemia measured with the enzymatic method vary between 60 - 105 mg / dl. The change of these values according to the reference laboratory has been the basis of the study.
10 minutes
Study Arms (2)
Control Group
NO INTERVENTIONThe control group did not received any treatment
Manipulation
EXPERIMENTALExperimental group received the osteopathic maneuver and the blood value were measured at baseline, after 2,5 and 10 minutes.
Interventions
Eligibility Criteria
You may qualify if:
- students between 18-27 years old
- healthy persons
- Acceptance of informed consent
You may not qualify if:
- pancreatitis
- diabetes I,II type
- anemia
- Alcohol intake for 12 hours prior.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 20, 2019
First Posted
February 25, 2019
Study Start
December 1, 2014
Primary Completion
June 1, 2015
Study Completion
May 1, 2017
Last Updated
February 25, 2019
Record last verified: 2019-02